| Code | Description | Claims | Beneficiaries | Total Paid |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
19,876 |
18,688 |
$2.88M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
10,859 |
10,184 |
$2.37M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
2,119 |
2,039 |
$1.29M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
2,669 |
2,496 |
$635K |
| 70450 |
Computed tomography, head or brain; without contrast material |
2,140 |
2,038 |
$496K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
12,851 |
3,605 |
$492K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
4,960 |
4,789 |
$414K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
689 |
661 |
$369K |
| 87428 |
|
6,461 |
6,246 |
$293K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
4,950 |
4,421 |
$233K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
3,822 |
3,662 |
$224K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
3,453 |
2,454 |
$211K |
| 71045 |
Radiologic examination, chest; single view |
5,182 |
4,875 |
$203K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
4,129 |
3,595 |
$192K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
5,356 |
4,745 |
$189K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
6,174 |
5,204 |
$154K |
| 71046 |
Radiologic examination, chest; 2 views |
3,127 |
2,971 |
$150K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
2,113 |
1,698 |
$139K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
4,361 |
4,079 |
$129K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
2,742 |
2,563 |
$103K |
| 80053 |
Comprehensive metabolic panel |
11,468 |
10,336 |
$82K |
| 97014 |
|
3,101 |
1,232 |
$78K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
12,904 |
11,388 |
$71K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
4,860 |
4,743 |
$55K |
| 97161 |
|
1,508 |
1,184 |
$52K |
| 74018 |
|
652 |
613 |
$41K |
| 72100 |
|
779 |
756 |
$41K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,557 |
1,393 |
$38K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
654 |
623 |
$37K |
| 73630 |
|
698 |
672 |
$35K |
| 96376 |
|
1,033 |
829 |
$32K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
3,097 |
2,932 |
$31K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
100 |
97 |
$31K |
| 84484 |
|
3,204 |
2,749 |
$30K |
| 73610 |
|
478 |
466 |
$24K |
| 81025 |
|
4,062 |
3,892 |
$20K |
| 73130 |
|
381 |
369 |
$17K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
101 |
97 |
$17K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,366 |
2,273 |
$17K |
| 83880 |
|
611 |
548 |
$14K |
| 71250 |
|
51 |
51 |
$13K |
| 81001 |
|
6,850 |
6,385 |
$13K |
| 83690 |
|
2,737 |
2,560 |
$13K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,358 |
1,689 |
$12K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
27 |
25 |
$12K |
| 87807 |
|
1,580 |
1,548 |
$12K |
| 73560 |
|
303 |
293 |
$11K |
| 87088 |
|
2,302 |
2,175 |
$11K |
| 87430 |
|
1,409 |
1,371 |
$10K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
28 |
26 |
$10K |
| 73030 |
|
183 |
172 |
$9K |
| 36415 |
Collection of venous blood by venipuncture |
13,183 |
10,859 |
$9K |
| 97164 |
|
774 |
639 |
$8K |
| 76000 |
|
107 |
89 |
$8K |
| 97162 |
|
252 |
233 |
$8K |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
107 |
96 |
$8K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
30 |
25 |
$8K |
| 66984 |
Extracapsular cataract removal with insertion of intraocular lens prosthesis |
14 |
13 |
$7K |
| 87070 |
|
1,212 |
1,179 |
$7K |
| 87040 |
|
578 |
466 |
$6K |
| 73110 |
|
164 |
157 |
$6K |
| 85379 |
|
758 |
729 |
$6K |
| 87186 |
|
1,004 |
958 |
$6K |
| 82962 |
|
2,591 |
1,777 |
$5K |
| 87077 |
|
1,106 |
1,054 |
$5K |
| 83605 |
|
631 |
566 |
$5K |
| 81003 |
|
3,339 |
3,183 |
$5K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
3,504 |
3,105 |
$5K |
| 83735 |
|
1,358 |
1,002 |
$5K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
295 |
114 |
$4K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
134 |
80 |
$4K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
166 |
160 |
$4K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
13 |
13 |
$3K |
| 84443 |
Thyroid stimulating hormone (TSH) |
196 |
187 |
$3K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
2,033 |
1,748 |
$3K |
| 76536 |
|
14 |
13 |
$3K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
664 |
584 |
$2K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
3,319 |
3,131 |
$2K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
134 |
64 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
360 |
355 |
$2K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
5,166 |
4,601 |
$2K |
| 76775 |
|
12 |
12 |
$2K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
90 |
89 |
$1K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
1,148 |
933 |
$1K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,421 |
1,092 |
$1K |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
549 |
497 |
$1K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
90 |
89 |
$1K |
| 86140 |
|
331 |
262 |
$1K |
| 85610 |
|
411 |
380 |
$1K |
| 85027 |
|
301 |
170 |
$950.40 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,739 |
1,481 |
$929.05 |
| 73502 |
|
19 |
17 |
$609.15 |
| 73080 |
|
15 |
15 |
$603.42 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
935 |
856 |
$389.67 |
| 82550 |
|
161 |
128 |
$387.23 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
344 |
316 |
$363.47 |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
20 |
12 |
$359.58 |
| 80061 |
Lipid panel |
45 |
43 |
$325.51 |
| J2704 |
Injection, propofol, 10 mg |
218 |
141 |
$301.46 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
71 |
64 |
$281.44 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
1,915 |
1,357 |
$280.41 |
| 84703 |
|
44 |
44 |
$262.18 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
324 |
286 |
$253.12 |
| 87210 |
|
41 |
39 |
$191.13 |
| 85730 |
|
43 |
41 |
$154.40 |
| 84702 |
|
29 |
28 |
$153.17 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
42 |
40 |
$131.73 |
| 73090 |
|
13 |
13 |
$127.54 |
| J1094 |
Injection, dexamethasone acetate, 1 mg |
205 |
199 |
$117.42 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
85 |
81 |
$103.36 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,089 |
773 |
$91.80 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
26 |
25 |
$67.82 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
26 |
24 |
$65.08 |
| 82565 |
|
12 |
12 |
$47.31 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
33 |
26 |
$40.60 |
| J2060 |
Injection, lorazepam, 2 mg |
57 |
27 |
$35.95 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
87 |
54 |
$32.25 |
| J1956 |
Injection, levofloxacin, 250 mg |
13 |
12 |
$29.66 |
| C9113 |
Injection, pantoprazole sodium, per vial |
21 |
12 |
$26.08 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
1,702 |
1,447 |
$0.10 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
17 |
12 |
$0.00 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
14 |
12 |
$0.00 |
| C1780 |
Lens, intraocular (new technology) |
13 |
12 |
$0.00 |